What is the influence of vaccination's routes on the regression of tumors located at mucosal sites?

OncoImmunology

Volumn 1, Issue 2, 2012, Pages 242-243

  Nardelli Haefliger, Denise ^a   Romero, Pedro ^b   Jichlinski, Patrice ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; CPG OLIGODEOXYNUCLEOTIDE; INTERCELLULAR ADHESION MOLECULE 1; PROTEIN E6; PROTEIN E7; VASCULAR CELL ADHESION MOLECULE 1;

ADJUVANT THERAPY; CANCER ADJUVANT THERAPY; CANCER IMMUNIZATION; CYTOTOXIC T LYMPHOCYTE; DRUG ADMINISTRATION ROUTE; DRUG EFFICACY; FEMALE GENITAL TRACT TUMOR; HUMAN PAPILLOMAVIRUS E6 ONCOGENE; HUMAN PAPILLOMAVIRUS E7 ONCOGENE; MUCOSA; NONHUMAN; NOTE; ONCOGENE; PANCREAS ISLET CELL TUMOR; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TREATMENT OUTCOME; TUMOR LOCALIZATION; TUMOR MODEL; TUMOR REGRESSION; UTERINE CERVIX CANCER;

EID: 84870444461     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.1.2.18204     Document Type: Note

References (10)

1. Decrausaz L, Goncalves A-R, Domingos-Pereira S, Pythoud C, Stehle JC, Schiller J, et al. A novel mucosal orthotopic murine model of Human papillomavriusassociated genital cancers. Int J Cancer 2011; 128:2105-13; http://dx.doi.org/10.1002/ijc.25561
2. Decrausaz L, Domingos-Pereira S, Duc M, Bobst M, Romero P, Schiller JT, et al. Parenteral but not mucosal immunization is able to induce regression of human papillomavirus associated genital tumors. Int J Cancer 2011; 129:762-72; http://dx.doi.org/10.1002/ijc.25973
3. Kaufman DR, Barouch DH. Translational mini-review series on vaccines for HIV: T lymphocyte trafficking and vaccine-elicited mucosal immunity. Clin Exp Immunol 2009; 157:165-73; http://dx.doi.org/10.1111/j.1365-2249.2009.03927.x
4. Belyakov IM, Ahlers JD. What role does the route of immunization play in the generation of protective immunity against mucosal pathogens? J Immunol 2009; 183:6883-92; http://dx.doi.org/10.4049/jimmunol.0901466
5. Decrausaz L, Revaz V, Bobst M, Corthésy B, Romero P, Nardelli-Haefliger D. Induction of Human Papillomavirus oncogene-specific CD8 T cell effector responses in the genital mucosa of vaccinated mice. Int J Cancer 2010; 126:2469-78.
6. Kelly KA, Chan AM, Butch A, Darville T. Two Different Homing Pathways Involving Integrin beta7 and E-selectin Significantly Influence Trafficking of CD4 Cells to the Genital Tract Following Chlamydia muridarum Infection. Am J Reprod Immunol 2009; 61:438-45.
7. Koelle DM, Gonzalez JC, Johnson AS. Homing in on the cellular immune response to HSV-2 in humans. Am J Reprod Immunol 2005; 53:172-81; http://dx.doi.org/10.1111/j.1600-0897.2005.00262.x
8. Fisher DT, Chen Q, Appenheimer MM, Skitzki J, Wang WC, Odunsi K, et al. Hurdles to lymphocyte trafficking in the tumor microenvironment: implications for effective immunotherapy. Immunol Invest 2006; 35:251-77; http://dx.doi.org/10.1080/08820130600745430
9. Marttila-Ichihara F, Castermans K, Auvinen K, Oude Egbrink MG, Jalkanen S, Griffioen AW, et al. Smallmolecule inhibitors of vascular adhesion protein-1 reduce the accumulation of myeloid cells into tumors and attenuate tumor growth in mice. J Immunol 2010; 184:3164-73; http://dx.doi.org/10.4049/jimmunol.0901794
10. Garbi N, Arnold B, Gordon S, Hammerling GJ, Ganss R. CpG motifs as proinflammatory factors render autochthonous tumors permissive for infiltration and destruction. J Immunol 2004; 172:5861-9.